CN103980886A - Fluorescent molecular probe, and preparation method and application thereof - Google Patents
Fluorescent molecular probe, and preparation method and application thereof Download PDFInfo
- Publication number
- CN103980886A CN103980886A CN201410231022.9A CN201410231022A CN103980886A CN 103980886 A CN103980886 A CN 103980886A CN 201410231022 A CN201410231022 A CN 201410231022A CN 103980886 A CN103980886 A CN 103980886A
- Authority
- CN
- China
- Prior art keywords
- molecular probe
- fluorescent molecular
- limited
- luminophore
- alkyl chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003068 molecular probe Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 229920001184 polypeptide Polymers 0.000 claims abstract description 40
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 39
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 38
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 30
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 30
- 125000003368 amide group Chemical group 0.000 claims description 13
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 11
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical group CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims description 11
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 11
- 229930182817 methionine Natural products 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 125000000729 N-terminal amino-acid group Chemical group 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 6
- 239000005642 Oleic acid Substances 0.000 claims description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- PWYVVBKROXXHEB-UHFFFAOYSA-M trimethyl-[3-(1-methyl-2,3,4,5-tetraphenylsilol-1-yl)propyl]azanium;iodide Chemical compound [I-].C[N+](C)(C)CCC[Si]1(C)C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 PWYVVBKROXXHEB-UHFFFAOYSA-M 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- JLZUZNKTTIRERF-UHFFFAOYSA-N tetraphenylethylene Chemical group C1=CC=CC=C1C(C=1C=CC=CC=1)=C(C=1C=CC=CC=1)C1=CC=CC=C1 JLZUZNKTTIRERF-UHFFFAOYSA-N 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 238000004020 luminiscence type Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000012964 benzotriazole Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 3
- 238000002372 labelling Methods 0.000 abstract description 3
- 239000004475 Arginine Substances 0.000 description 13
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000007821 HATU Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- YPTNAIDIXCOZAJ-LHEWISCISA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-6-[[(4-methylphenyl)-diphenylmethyl]amino]hexanoic acid Chemical compound C1=CC(C)=CC=C1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)NCCCC[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 YPTNAIDIXCOZAJ-LHEWISCISA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- -1 hexafluorophosphate Chemical compound 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to a fluorescent molecular probe, and a preparation method and application thereof. The fluorescent molecular probe disclosed by the invention comprises hydrophilic polypeptide, a hydrophobic alkyl chain and a limited luminophore, wherein the hydrophobic alkyl chain and the limited luminophore are connected to the same end of hydrophilic polypeptide. According to the fluorescent molecular probe disclosed by the invention, the hydrophilic polypeptide is capable of increasing the solubility and the stability of the fluorescent molecular probe in an aqueous solution; the hydrophobic alkyl chain can be embedded into a cytomembrane; the limited luminophore only emits fluorescent light under a limited condition; the fluorescent molecular probe is strong in stability and good in specificity, thereby being a good fluorescent molecular probe capable of being used for labelling cytomembranes and applied in biological or medical research. The preparation method of the fluorescent molecular probe disclosed by the invention is simple and easy to do; complex operation and severe conditions are not related; furthermore, the preparation method disclosed by the invention is relatively low in cost and good in optical stability.
Description
Technical field
The present invention relates to fluorescent molecular probe field, relate in particular to a kind of fluorescent molecular probe for cytolemma mark and its preparation method and application.
Background technology
Fluorescent molecular probe is to be based upon in spectrochemistry and optical waveguide and Foundation of Measurement Technology, optionally changes continuously the chemistry of analytic target and structural information into the analytical instrument easily molecule measuring apparatus of the fluorescent signal of measurement.Fluorescent molecular probe is subject to the impact of surrounding environment, shows different fluorescent characteristics under different condition.When in a certain specific environment, fluorescent molecular probe fluorescent characteristic changes, and as growing out of nothing of fluorescence, or the change of excitation wavelength, emission wavelength, thereby makes people know certain customizing messages existing in the feature of surrounding environment or environment.That fluorescent molecular probe has is highly sensitive, selectivity good, easy to use, cost is low, do not need pre-treatment, be not subject to that external electromagnetic field affects, the remote plurality of advantages such as luminous.Fluorescent molecular probe is comprised of recognition group and reporter group conventionally, and the former has determined selectivity and the specificity of probe molecule, and latter has determined the sensitivity of identification.
In biomedical research, people usually need labeled cell film with form and the size of observation of cell, or observe the position relationship of specific protein, vesica and cytolemma.Yet existing membrane molecule probe has the shortcomings such as poor specificity, easy photobleaching, has limited its application, cannot meet the demand of scientific research.
Summary of the invention
For the deficiencies in the prior art, the invention provides a kind of fluorescent molecular probe for cytolemma mark, its cell membrane has specific marker ability, and the rear luminophore of being combined with cytolemma has fluorescence, therefore showed cell film location is a kind of fluorescent molecular probe that can be used in cytolemma mark.The present invention also provides the preparation method and application of described fluorescent molecular probe, and its preparation method is simple, does not relate to complicated operation and severe condition, and cost is lower, and optical stability is good.
For realizing object of the present invention, the invention provides following technical scheme:
In first aspect, the invention provides a kind of fluorescent molecular probe, comprise hydrophilic polypeptide and be connected in described hydrophilic polypeptide with hydrophobic alkyl chain and the limited luminophore of one end.
In fluorescent molecular probe of the present invention, described hydrophobic alkyl chain can embed cytolemma and cause luminophore limited, and emitting fluorescence under laser radiation is realized the specific marker of cell membrane.In fluorescent molecular probe of the present invention, hydrophilic polypeptide can improve stability and the targeting of probe in the aqueous solution, hydrophobic alkyl chain can embed cytolemma, and luminophore is emitting fluorescence under confined condition only, is therefore a kind of good fluorescent molecular probe that can be used for cytolemma mark.
In the present invention, covalently bound between described hydrophobic alkyl chain and limited luminophore and hydrophilic polypeptide can be stable covalent linkage arbitrarily, as long as can realize three's connection, such as amido linkage, ester bond or ehter bond etc.Certainly, also comprise the covalent linkage connection type of developing future.
As the preferred technical solution of the present invention, described hydrophobic alkyl chain is all connected with described hydrophilic polypeptid covalence by amido linkage with limited luminophore.
Verified, adopt amido linkage connection can realize hydrophobic alkyl chain and be connected with the efficient, stable of hydrophilic polypeptide with limited luminophore, it is all very single-minded and stable that two amido linkages connect, and can not produce interference to three partial functions.
As the preferred technical solution of the present invention, on the side chain R base of the n terminal amino acid of described hydrophilic polypeptide, there is amino group, described amino group and described hydrophobic alkyl chain formation amido linkage are covalently bound; It is covalently bound that the amino and described limited luminophore of α of the n terminal amino acid of described hydrophilic polypeptide forms amido linkage.The n terminal amino acid of described hydrophilic polypeptide is such as Methionin, arginine, l-asparagine and glutamine etc.
As the preferred technical solution of the present invention, the n terminal amino acid of described hydrophilic polypeptide is Methionin, and the side chain of described Methionin is amino covalently bound with described hydrophobic alkyl chain formation amido linkage; It is covalently bound that the amino and described limited luminophore of α of described Methionin forms amido linkage.
As the preferred technical solution of the present invention, the carbochain of described hydrophobic alkyl chain contains 8-20 carbon atom, for example 8,9,10,11,12,13,14,15,16,17,18,19 or 20 carbon atoms, are preferably 12-20 carbon atom, more preferably palmitinic acid, oleic acid or stearic acid.In above-mentioned scope, the ability that hydrophobic alkyl chain embeds cytolemma is stronger, and the molecular probe obtaining has good stability.
As the preferred technical solution of the present invention, described hydrophilic polypeptide is with positive charge, is preferably to take the polypeptide that positively charged amino acid is main composition, more preferably contains arginic polypeptide.Except arginine, can also contain Methionin or Histidine etc.The positively charged hydrophilic polypeptide that above-mentioned amino acid forms can promote itself and cell to be in contact with one another when improving fluorescent molecular probe stability, thereby improves specificity.
As the preferred technical solution of the present invention, described limited luminophore is limited induced luminescence molecule, is preferably tetraphenyl ethylene molecule or Silole.Above-mentioned limited induced luminescence molecule has the limited characteristics of luminescence of molecular rotation, and has the stable advantages such as cancellation, luminous efficiency height that are difficult for of fluorescence.
In second aspect, the invention provides a kind of method of preparing the fluorescent molecular probe described in first aspect, comprising: same one end of hydrophobic alkyl chain and limited luminophore and hydrophilic polypeptide is connected to form to described fluorescent molecular probe.
As the preferred technical solution of the present invention, described method comprises: under the existence of catalyzer, make respectively to contact with the amino of hydrophilic polypeptide with limited luminophore with the hydrophobic alkyl chain of carboxyl, form amido linkage covalently bound, obtain described fluorescent molecular probe.
Preferably, described catalyzer is 2-(7-azo benzotriazole)-N, N, N', N'-tetramethyl-urea phosphofluoric acid ester and DIPEA.
In the method for the invention, the characteristic of hydrophilic polypeptide, hydrophobic alkyl chain and limited luminophore and selection, as described in first aspect, do not repeat them here.
In the third aspect, the invention provides the application in cytolemma mark of fluorescent molecular probe as described in first aspect.
Compared to existing technology, beneficial effect of the present invention is: in fluorescent molecular probe of the present invention, hydrophilic polypeptide can improve solvability and the stability of fluorescent molecular probe in the aqueous solution, and hydrophobic alkyl chain can embed cytolemma, and limited luminophore is emitting fluorescence under confined condition only.This fluorescent molecular probe stability is strong, specificity good, is therefore a kind of good fluorescent molecular probe that can be used for cytolemma mark, can be applicable in biology or medical research.The preparation method of fluorescent molecular probe of the present invention, simple, do not relate to complicated operation and severe condition, and cost is lower, optical stability is good.
Accompanying drawing explanation
Fig. 1 is the fluorescent molecular probe of the embodiment of the present invention 1 preparation mark effect of cell membrane (shooting of single-photon laser Laser Scanning Confocal Microscope) after incubated cell 30min under 50 μ M concentration.
Fig. 2 is the fluorescent molecular probe of the embodiment of the present invention 1 preparation mark effect of cell membrane (shooting of two-photon laser Laser Scanning Confocal Microscope) after incubated cell 30min under 50 μ M concentration.
Embodiment
Below in conjunction with embodiment, embodiment of the present invention are described in detail.It will be understood to those of skill in the art that following examples are only the preferred embodiments of the present invention, so that understand better the present invention, thereby should not be considered as limiting scope of the present invention.
Experimental technique in following embodiment, if no special instructions, is ordinary method; Experiment material used, if no special instructions, is and is purchased available from routine biochemistry chemical reagent work.
Amino acid (Fmoc-amino acids), 2-(7-azo the benzotriazole)-N of the source of material therefor: Fmoc protection in embodiment, N, N', N'-tetramethyl-urea phosphofluoric acid ester (O-(7-Azabenzotriazole-1-yl)-1,1,3,3-tetramethyluronilum hexafluorophosphate, HATU) and DIPEA (diisopropylethylamine, DIEA) all purchased from Beijing Bo Maijie Science and Technology Ltd.; Palmitinic acid (>=99%, palmitic acid), oleic acid (>=99%, oleic acid), stearic acid (>=99%, stearic acid) are all purchased from Sigma-Aldrich (St Louis, the U.S.) company; Carboxylated tetraphenyl ethene (TPE-COOH) (people such as reference Chunqiu Zhang, Imaging Intracellular Anti-Cancer Drug Delivery by Self-Assembly Micelles with Aggregation-Induced Emission (AIE Micelles) .ACS Applied Materials & Interfaces.2014.9; 6 (7): 5212-5220.) and Silole (silole) (reference Silole-Containing Polyacetylenes.Synthesis, Thermal Stability, Light Emission, Nanodimensional Aggregation, and Restricted Intramolecular Rotation.Macromolecules, 2003,36 (4), pp1108 – 1117) be that oneself is synthetic; All chemical reagent are not with all processing through other before, and the ultrapure water that whole experiment is used adopts the Milli-Q tri-distilled water (18.2M Ω cm, Millipore System Inc.) of Millipore Corp..
Embodiment 1
Polypeptide (the RRRR that the present embodiment forms with 4 arginine, R4, SEQ ID NO:1) as hydrophilic polypeptide, carboxylated tetraphenyl ethene (TPE-COOH), as limited luminophore, palmitinic acid, as hydrophobic alkyl chain, be example, the preparation of fluorescent molecular probe is described.By this fluorescent molecular probe called after TR4, hereinafter TR4 all refers to this probe.Wherein arginine positively charged, therefore R4 polypeptide presents positive polarity, has affinity to cell.Methionin N end of the follow-up connection of arginine and side chain end two are amino for being connected TPE-COOH and palmitinic acid.The carboxyl of palmitinic acid is easy to reaction, and hydrophobic alkyl chain can embed in cytolemma, and fixing whole fluorescent molecular probe.TPE molecule is not luminous under free state, once probe is incorporated into cytolemma, and phenyl ring limited in rotation, TPE emitting fluorescence.Its optimum excitation wavelength is 330nm, and emission wavelength is 466nm.Following formula is the molecular structure of synthetic TR4.
The specific experiment step of synthetic TR4 is as follows:
Adopt CLEAR Amide polypeptide synthetic resins, utilize the solid-phase peptide synthetic method of Fmoc chemistry, connect successively arginine, arginine, arginine, arginine, Methionin (Fmoc-Lys (MTT)-OH).Under 3% trifluoroacetic acid condition, slough the Side chain protective group MTT of Methionin (Fmoc-Lys (MTT)-OH), adopt condensation reagent HATU and DIEA palmitinic acid to be connected to the side chain of Methionin.Under 20% piperidines condition, deviate from Fmoc group, adopt condensation reagent HATU and DIEA TPE-COOH to be connected to the N-terminal of Methionin.With trifluoroacetic acid, cut polypeptide, cold diethyl ether precipitation, collects TR4 crude product high performance liquid chromatography purifying afterwards, and freeze-drying, obtains final product probe.
Finally, cell membrane is marked as picture, and specific experiment step is as follows:
The TR4 making with the present embodiment is hatched breast cancer cell MCF-730min under 50 μ M concentration, imaging under single photon or two-photon laser Laser Scanning Confocal Microscope, by observing TPE fluorescence, determine cytolemma position and form, as depicted in figs. 1 and 2, Fig. 1 and Fig. 2 all show the fluorescent signal along cytolemma to result.
Result shows: the cytolemma of TR4 mark is continuous, complete, does not occur TPE fluorescence in endochylema, and TR4 mark has been described cytolemma has good mark specificity.Cellular form is good, and TR4 itself and labeling process can not produce toxicity to cell, are applicable to viable cell labelling.
Embodiment 2 (changing amino acid forms)
The difference of the present embodiment and embodiment 1 is to change 4 arginine in embodiment 1 into 2 arginine and 2 Methionins (RKRK, SEQ ID NO:2), prepares to take the fluorescent molecular probe that RKRK is hydrophilic polypeptide.
The cytolemma mark result that the fluorescent molecular probe making with the present embodiment carries out is similar to embodiment's 1.
Embodiment 3 (changing polypeptide length)
The difference of the present embodiment and embodiment 1 is to change 4 arginine in embodiment 1 into 8 arginine, prepares with RRRRRRRR SEQ ID NO:3) be the fluorescent molecular probe of hydrophilic polypeptide.
The cytolemma mark result that the fluorescent molecular probe making with the present embodiment carries out is similar to embodiment's 1.
Embodiment 4 (changing hydrophobic alkyl chain length)
The difference of the present embodiment and embodiment 1 is to change the palmitinic acid in embodiment 1 into oleic acid, prepares to take the fluorescent molecular probe of oleic acid as hydrophobic alkyl chain.
The cytolemma mark result that the fluorescent molecular probe making with the present embodiment carries out is similar to embodiment's 1.
Embodiment 5 (changing hydrophobic alkyl chain length)
The difference of the present embodiment and embodiment 1 is to change the palmitinic acid in embodiment 1 into stearic acid, prepares to take the fluorescent molecular probe of stearic acid as hydrophobic alkyl chain.
The cytolemma mark result that the fluorescent molecular probe making with the present embodiment carries out is similar to embodiment's 1.
Embodiment 6 (changing limited luminophore)
The difference of the present embodiment and embodiment 1 is to change the tetraphenyl ethene in embodiment 1 into Silole, prepares to take the fluorescent molecular probe that Silole is limited luminophore.
The cytolemma mark result that the fluorescent molecular probe making with the present embodiment carries out is similar to embodiment's 1.
Applicant's statement, the present invention illustrates detailed features of the present invention and detailed method by above-described embodiment, but the present invention is not limited to above-mentioned detailed features and detailed method, do not mean that the present invention must rely on above-mentioned detailed features and detailed method could be implemented.Person of ordinary skill in the field should understand, any improvement in the present invention is selected the selection of the equivalence replacement of component and the interpolation of ancillary component, concrete mode etc., within all dropping on protection scope of the present invention and open scope to the present invention.
Claims (10)
1. a fluorescent molecular probe, comprises hydrophilic polypeptide and is connected in described hydrophilic polypeptide with hydrophobic alkyl chain and the limited luminophore of one end.
2. fluorescent molecular probe according to claim 1, is characterized in that, described hydrophobic alkyl chain is all connected with described hydrophilic polypeptid covalence by amido linkage with limited luminophore.
3. fluorescent molecular probe according to claim 1 and 2, is characterized in that, on the side chain R base of the n terminal amino acid of described hydrophilic polypeptide, has amino group, and described amino group and described hydrophobic alkyl chain formation amido linkage are covalently bound; It is covalently bound that the amino and described limited luminophore of α of the n terminal amino acid of described hydrophilic polypeptide forms amido linkage.
4. according to the fluorescent molecular probe described in claim 1-3 any one, it is characterized in that, the n terminal amino acid of described hydrophilic polypeptide is Methionin, and the side chain of described Methionin is amino covalently bound with described hydrophobic alkyl chain formation amido linkage; It is covalently bound that the amino and described limited luminophore of α of described Methionin forms amido linkage.
5. according to the fluorescent molecular probe described in claim 1-4 any one, it is characterized in that, the carbochain of described hydrophobic alkyl chain contains 8-20 carbon atom, is preferably 12-20 carbon atom, more preferably palmitinic acid, oleic acid or stearic acid.
6. according to the fluorescent molecular probe described in claim 1-5 any one, it is characterized in that, described hydrophilic polypeptide is with positive charge, is preferably to take the polypeptide that positively charged amino acid is main composition, more preferably contains arginic polypeptide.
7. according to the fluorescent molecular probe described in claim 1-6 any one, it is characterized in that, described limited luminophore is limited induced luminescence molecule, is preferably tetraphenyl ethylene molecule or Silole.
8. a method of preparing the fluorescent molecular probe described in claim 1-7 any one, comprising: same one end of hydrophobic alkyl chain and limited luminophore and hydrophilic polypeptide is connected to form to described fluorescent molecular probe.
9. method according to claim 8, it is characterized in that, described method comprises: under the existence of catalyzer, make respectively to contact with the amino of hydrophilic polypeptide with limited luminophore with the hydrophobic alkyl chain of carboxyl, formation amido linkage is covalently bound, obtains described fluorescent molecular probe;
Preferably, described catalyzer is 2-(7-azo benzotriazole)-N, N, N', N'-tetramethyl-urea phosphofluoric acid ester and DIPEA.
10. the application of the fluorescent molecular probe as described in claim 1-7 any one in cytolemma mark.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410231022.9A CN103980886B (en) | 2014-05-28 | 2014-05-28 | A kind of fluorescent molecular probe and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410231022.9A CN103980886B (en) | 2014-05-28 | 2014-05-28 | A kind of fluorescent molecular probe and its preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103980886A true CN103980886A (en) | 2014-08-13 |
| CN103980886B CN103980886B (en) | 2015-12-09 |
Family
ID=51273061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410231022.9A Expired - Fee Related CN103980886B (en) | 2014-05-28 | 2014-05-28 | A kind of fluorescent molecular probe and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103980886B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106841134A (en) * | 2017-01-05 | 2017-06-13 | 国家纳米科学中心 | Amphipathic fluorescent molecular probe detects the application in Dental plaque biofilm in vitro |
| CN106867513A (en) * | 2015-12-11 | 2017-06-20 | 中国科学院大连化学物理研究所 | A kind of cell membrane localization zinc ion fluorescent and its preparation method and application |
| CN108707183A (en) * | 2018-05-22 | 2018-10-26 | 桂林市兴达光电医疗器械有限公司 | Tyroserleutide-chlorin e 6 monoesters and preparation method thereof |
| CN108771759A (en) * | 2018-05-22 | 2018-11-09 | 桂林市兴达光电医疗器械有限公司 | Tyroserleutide-chlorin e 6 metal complex ester and preparation method thereof |
| CN108840907A (en) * | 2018-05-22 | 2018-11-20 | 桂林市兴达光电医疗器械有限公司 | Tyroserleutide-Phephorbide a monoesters and preparation method thereof |
| CN110041916A (en) * | 2019-05-16 | 2019-07-23 | 南京中医药大学 | A kind of endotoxic aggregation inducing fluorescent polypeptide probe preparation of detection bacterium and application |
| CN110272470A (en) * | 2019-05-10 | 2019-09-24 | 天津科技大学 | A kind of polypeptide and its probe and preparation method for detection of organic phosphorus pesticide |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013029340A1 (en) * | 2011-09-01 | 2013-03-07 | The Hong Kong University Of Science And Technology | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging |
| CN103096935A (en) * | 2010-08-23 | 2013-05-08 | 株式会社岛津制作所 | Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same |
| CN103529017A (en) * | 2013-10-09 | 2014-01-22 | 国家纳米科学中心 | Enzyme-responsive self-aggregation luminous molecule and applications thereof in monitoring enzyme activity |
-
2014
- 2014-05-28 CN CN201410231022.9A patent/CN103980886B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103096935A (en) * | 2010-08-23 | 2013-05-08 | 株式会社岛津制作所 | Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same |
| WO2013029340A1 (en) * | 2011-09-01 | 2013-03-07 | The Hong Kong University Of Science And Technology | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging |
| CN103529017A (en) * | 2013-10-09 | 2014-01-22 | 国家纳米科学中心 | Enzyme-responsive self-aggregation luminous molecule and applications thereof in monitoring enzyme activity |
Non-Patent Citations (6)
| Title |
|---|
| H. SHI等: "Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics for In Vivo Imaging of Cell Apoptosis", 《ORG. BIOMOL. CHEM.》, 10 September 2013 (2013-09-10) * |
| M. LIU等: "An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy", 《BIOMATERIALS》, vol. 33, 16 November 2011 (2011-11-16), pages 2240 - 2250, XP028442473, DOI: doi:10.1016/j.biomaterials.2011.11.082 * |
| 李民，等: "具有聚集诱导发光特性的四苯基乙烯在细胞成像中的应用及细胞毒性检测", 《华中科技大学学报》, vol. 40, no. 3, 30 June 2011 (2011-06-30), pages 279 - 282 * |
| 赵跃智，等: "聚集诱导发光体系: 化合物种类、发光机制及其应用", 《化学进展》, vol. 25, no. 23, 30 March 2013 (2013-03-30), pages 296 - 321 * |
| 黄嫣嫣，赵睿: "基于靶向多肽探针的蛋白质分析检测新方法", 《分析测试学报》, vol. 31, no. 9, 30 September 2012 (2012-09-30), pages 1184 - 1190 * |
| 黄志平，等: "多肽荧光探针在蛋白质检测中的应用", 《中国科学：化学》, vol. 43, no. 8, 20 June 2013 (2013-06-20), pages 1013 - 1021 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106867513A (en) * | 2015-12-11 | 2017-06-20 | 中国科学院大连化学物理研究所 | A kind of cell membrane localization zinc ion fluorescent and its preparation method and application |
| CN106841134A (en) * | 2017-01-05 | 2017-06-13 | 国家纳米科学中心 | Amphipathic fluorescent molecular probe detects the application in Dental plaque biofilm in vitro |
| CN108707183A (en) * | 2018-05-22 | 2018-10-26 | 桂林市兴达光电医疗器械有限公司 | Tyroserleutide-chlorin e 6 monoesters and preparation method thereof |
| CN108771759A (en) * | 2018-05-22 | 2018-11-09 | 桂林市兴达光电医疗器械有限公司 | Tyroserleutide-chlorin e 6 metal complex ester and preparation method thereof |
| CN108840907A (en) * | 2018-05-22 | 2018-11-20 | 桂林市兴达光电医疗器械有限公司 | Tyroserleutide-Phephorbide a monoesters and preparation method thereof |
| CN110272470A (en) * | 2019-05-10 | 2019-09-24 | 天津科技大学 | A kind of polypeptide and its probe and preparation method for detection of organic phosphorus pesticide |
| CN110041916A (en) * | 2019-05-16 | 2019-07-23 | 南京中医药大学 | A kind of endotoxic aggregation inducing fluorescent polypeptide probe preparation of detection bacterium and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103980886B (en) | 2015-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103980886B (en) | A kind of fluorescent molecular probe and its preparation method and application | |
| Chang et al. | Highly fluorescent nanodiamonds protein‐functionalized for cell labeling and targeting | |
| Han et al. | Dual‐pH sensitive charge‐reversal polypeptide micelles for tumor‐triggered targeting uptake and nuclear drug delivery | |
| Mazzucchelli et al. | Orientation‐Controlled Conjugation of Haloalkane Dehalogenase Fused Homing Peptides to Multifunctional Nanoparticles for the Specific Recognition of Cancer Cells | |
| HRP20202019T1 (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| Lv et al. | Boronic acid-rich dendrimer for efficient intracellular peptide delivery | |
| Tian et al. | Live cell luminescence imaging as a function of delivery mechanism | |
| Zamuner et al. | Design of decorated self-assembling peptide hydrogels as architecture for mesenchymal stem cells | |
| Shiu et al. | Phosphorescent proteins for bio-imaging and site selective bio-conjugation of peptides and proteins with luminescent cyclometalated iridium (iii) complexes | |
| Delehanty et al. | Site-specific cellular delivery of quantum dots with chemoselectively-assembled modular peptides | |
| Kozhikhova et al. | A novel peptide dendrimer LTP efficiently facilitates transfection of mammalian cells | |
| Ruzza et al. | Cell-penetrating peptides: A comparative study on lipid affinity and cargo delivery properties | |
| Panigrahi et al. | Cyclic peptide-based nanostructures as efficient siRNA carriers | |
| Gemmill et al. | Evaluation of diverse peptidyl motifs for cellular delivery of semiconductor quantum dots | |
| CN106795205A (en) | Neoblast membrane penetrating peptide and its purposes as bioactivator carrier | |
| Zhan et al. | Tumor targeting with DGEA peptide ligands: a new aromatic peptide amphiphile for imaging cancers | |
| Yano et al. | Live-cell imaging of membrane proteins by a coiled-coil labeling method—Principles and applications | |
| Böhmová et al. | Polymer cancerostatics containing cell-penetrating peptides: internalization efficacy depends on peptide type and spacer length | |
| Frisch et al. | Probing the self-assembly and stability of oligohistidine based rod-like micelles by aggregation induced luminescence | |
| Chen et al. | Co-delivery of proapoptotic peptide and p53 DNA by reduction-sensitive polypeptides for cancer therapy | |
| US10918726B2 (en) | Carbosilane dendrimer and aggregatable carrier obtained using said dendrimer for drug delivery system | |
| Park et al. | EDB-FN Targeted Peptide–Drug Conjugates for Use against Prostate Cancer | |
| CN104017089A (en) | Ferritin heavy-chain subunit nanoparticles, and preparation method and application thereof | |
| Morillas-Becerril et al. | Multifunctional, CD44v6-targeted ORMOSIL nanoparticles enhance drugs toxicity in cancer cells | |
| Zhang et al. | Special method to prepare quantum dot probes with reduced cytotoxicity and increased optical property |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151209 |